Clinical Trials Browser

Phase 3 × INDUSTRY × Non Small Cell Lung Cancer Metastatic × Clear all

NCT05668650 2024-07-16

Double-blind Study to Evaluate the PK, Efficacy, Safety and Immunogenicity of MB12 Versus Keytruda® in Stage IV NSCLC

Phase 3 Recruiting

Non Small Cell Lung Cancer Metastatic